136 related articles for article (PubMed ID: 21062114)
1. Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy.
Donnenberg AD; Donnenberg VS; Griffin DL; Moore LR; Tekinturhan F; Kormos RL
Cytotherapy; 2011 Apr; 13(4):441-8. PubMed ID: 21062114
[TBL] [Abstract][Full Text] [Related]
2. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
3. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
[TBL] [Abstract][Full Text] [Related]
6. Highly purified CD34-positive cells reconstitute hematopoiesis.
Civin CI; Trischmann T; Kadan NS; Davis J; Noga S; Cohen K; Duffy B; Groenewegen I; Wiley J; Law P; Hardwick A; Oldham F; Gee A
J Clin Oncol; 1996 Aug; 14(8):2224-33. PubMed ID: 8708711
[TBL] [Abstract][Full Text] [Related]
7. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells.
Olivero S; Novakovitch G; Ladaique P; Sainty D; Viret F; Faucher C; Stoppa AM; Blaise D; Chabannon C
Cytotherapy; 1999; 1(6):469-77. PubMed ID: 20443236
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery.
Dotsenko O; Xiao Q; Xu Q; Jahangiri M
Ann Thorac Surg; 2010 Dec; 90(6):1944-51. PubMed ID: 21095342
[TBL] [Abstract][Full Text] [Related]
9. CD34+ cell engraftment, ex vivo expansion, and malignant cell depletion following immunomagnetic selection.
Huntenburg CC; Kunkel LA; Schneidkraut MJ
J Hematother; 1998 Apr; 7(2):175-83. PubMed ID: 9597575
[TBL] [Abstract][Full Text] [Related]
10. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL.
Paulus U; Schmitz N; Viehmann K; von Neuhoff N; Dreger P
Bone Marrow Transplant; 1997 Sep; 20(5):415-20. PubMed ID: 9339759
[TBL] [Abstract][Full Text] [Related]
11. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results.
Martín-Henao GA; Picón M; Amill B; Querol S; González JR; Martínez C; Martino R; Ferrá C; Brunet S; Grañena A; Sierra J; García J
Transfusion; 2000 Jan; 40(1):35-43. PubMed ID: 10644809
[TBL] [Abstract][Full Text] [Related]
12. Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.
Prince HM; Bashford J; Wall D; Rischin D; Parker N; Toner GC; Seymour JF; Blakey D; Haylock D; Simmons P; Francis P; Wolf M; Januszewicz EH; Richardson G; Scarlett J; Briggs P
Cytotherapy; 2002; 4(2):137-45. PubMed ID: 12006209
[TBL] [Abstract][Full Text] [Related]
13. [Application of double immunomagnetic positive sorting to ex vivo expansion of marrow CD34(+)CD59(+) cells from patients with paroxysmal nocturnal hemoglobinuria].
Xiao J; Wu YJ; Zhang ZN; Lu ZJ; Chen SP; Dong HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):179-83. PubMed ID: 12744742
[TBL] [Abstract][Full Text] [Related]
14. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
15. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
Bruno B; Nash RA; Wallace PM; Gass MJ; Thompson J; Storb R; McSweeney PA
Transplantation; 1999 Aug; 68(3):338-44. PubMed ID: 10459536
[TBL] [Abstract][Full Text] [Related]
16. Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods.
Martín-Henao GA; Picón M; Amill B; Querol S; Ferrà C; Grañena A; García J
Bone Marrow Transplant; 2001 Apr; 27(7):683-7. PubMed ID: 11360106
[TBL] [Abstract][Full Text] [Related]
17. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
20. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer.
Hohaus S; Pförsich M; Murea S; Abdallah A; Lin YS; Funk L; Voso MT; Kaul S; Schmid H; Wallwiener D; Haas R
Br J Haematol; 1997 Jun; 97(4):881-8. PubMed ID: 9217192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
